Mark Jay Zucker, MD, JD, FACC, FACP, FCCP

Professor

Contact Information

Mark J. Zucker, MD

33 S. 9th Street
Suite 630
Philadelphia, PA 19107

Email Mark Jay Zucker

856-557-5306
215-521-6195 fax

Professor

Education

Medical School

Northwestern University Medical School, Chicago, Il - 1981

Residency

Internal Medicine - Intern and Resident, McGraw Medical Center- Northwestern University, Chicago, IL - 1984

Fellowship

Clinical Fellow in Cardiology, McGraw Medical Center- Northwestern University, Chicago, IL - 1987

Research Fellow in Heart Failure, McGraw Medical Center- Northwestern University, Chicago, IL - 1985

Publications

Certifications

  • National Board of Medical Examiners
  • American Board of Internal Medicine (unlimited)
  • American Board of Internal Medicine- Subspecialty Section- cardiovascular diseases
  • North American Society for Pacing and Electrophysiology: Special Competency in Cardiac Pacing
  • American Board of Internal medicine- Advanced Heart Failure and Transplantation
  • Recertified American Board of Internal medicine- Advanced Heart Failure and Transplantation

Awards

  • NJBIZ ICON Award - 2019
  • MD Advantage – Edward J. Ill Physician’s Award - 2011
  • American Hospital Association – Physician Leader of the Year - 2010
  • American Heart Association – Northern New Jersey Division – Affair of the Heart Gala – Physician of the Year 2007 - 2007
  • Annual Heritage Award for Health Care Professional of the Year sponsored by the New Jersey Organ and Tissue Sharing Network - 2005
  • American Heart Association – Northern New Jersey Division - Affair of the Heart Gala – Co-recipient of the Harvey E. Nussbaum Distinguished Service Award - 2002
  • Transplant Recipient International Organization – New Jersey – 1998 Triangle Award – Health Care Professional of the Year - 1998

Research & Clinical Interests

Areas of clinical concentration involve the care and management of patients with advanced heart failure, peripartum cardiomyopathy, cardiac amyloidosis and sarcoidosis, mechanical circulatory support devices, and heart transplants. 

Research interests include participation in or development of trials involving alternative tacrolimus-based immunosuppression regimens, the use and toxicity of tyrosine kinase inhibitors in the treatment of scleroderma-associated lung disease and pulmonary hypertension, the management of heparin-induced thrombocytopenia, and the use of cardiac stem cell and gene therapies.